Medical Weight Loss for Tupelo, Mississippi Residents
Tupelo, Mississippi residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Tupelo through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Tupelo Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Tupelo, Mississippi residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Tupelo is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.
Patients across Tupelo and the surrounding area connect with Dr. Sharma by secure video, wherever they live in Mississippi. We care for patients throughout downtown Tupelo and the greater Lee County area of northeast Mississippi. Whether you are starting your first GLP-1 program or switching from a brand medication, your Tupelo treatment plan is built around your health history and goals.
Telehealth removes the distance between Tupelo and specialized care: your consultation happens wherever you are in Mississippi. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Tupelo patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Tupelo
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Tupelo
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Tupelo address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Tupelo
Does New Hope Weight Loss treat patients in Tupelo?
Yes. Although the clinic is in Costa Mesa, California, we treat Tupelo, Mississippi residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Tupelo?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Tupelo address in cold-pack packaging.
What do Tupelo patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Tupelo do you serve?
We serve patients from across Tupelo by telehealth, including downtown Tupelo and the greater Lee County area of northeast Mississippi.
How does compounded medication compare on cost for Tupelo patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Tupelo patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Tupelo, Mississippi by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.